Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2014 to 2024.
The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.
Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2014 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.
The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2014. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2014
- Browse co-promotion and co-marketing deals
- Benchmark analysis - identify market value of transactions
- Financials terms
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:
- Trends in co-promotion and co-marketing dealmaking in the biopharma industry
- Overview of co-promotion and co-marketing deal structure
- Directory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnology
- The leading co-promotion and co-marketing deals by value
- Most active co-promotion and co-marketing dealmakers
- The leading co-promotion and co-marketing partnering resources
In Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-promotion and co-marketing deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Medicines
- 4D Molecular Therapeutics
- Abbvie
- AbCellera Biologics
- ACADIA Pharmaceuticals
- Acceleron Pharma
- Accent Therapeutics
- ACEA Biosciences
- Acelrx Pharmaceuticals
- Acerus
- AC Immune
- Adaptimmune
- Adhera Therapeutics
- Advanced Cell Diagnostics
- AEterna Zentaris
- Affibody
- Affini-T Therapeutics
- Agena Bioscience
- Agenus Bio
- Agilent Technologies
- Agios Pharmaceuticals
- Ajinomoto
- Akeso Biopharma
- Akoya Biosciences
- Albany Molecular Research
- Aldeyra Therapeutics
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- ALK-Abello
- Allegis Pharmaceuticals
- Allergan
- Almirall
- Alnylam Pharmaceuticals
- Alyvant
- Amarin
- Amgen
- Amneal Pharmaceuticals
- AmpTec
- AMRA
- AnGes MG
- Apellis Pharmaceuticals
- Applied Genetic Technologies
- Aratana Therapeutics
- Arbor Biotechnologies
- Arcellx
- Arcturus Therapeutics
- Arcus Biosciences
- Arcutis Biotherapeutics
- Ardelyx
- argenx
- Aries Pharmaceuticals
- Arima Genomics
- Armune Bioscience
- ArQule
- Arrowhead Pharmaceuticals
- Arvinas
- Asahi Kasei
- Ascend Therapeutics
- Ascentage Pharma
- Assembly Biosciences
- Astellas Pharma
- Astex Pharmaceuticals
- AstraZeneca
- Aurigene Pharmaceutical Services
- Aytu BioPharma
- Basilea Pharmaceutica
- Bausch & Lomb
- Baxalta
- Bayer
- Beam Therapeutics
- BeiGene
- Beijing Minhai Biotechnology
- Belharra Therapeutics
- Belintra
- Berlin Chemie
- Bio-Rad Laboratories
- BioAge Labs
- BioDiscovery
- Biogen
- Biognosys
- Biological Industries
- BioNano Genomics
- BioNTech
- Bioverativ
- Blake Insomnia Therapeutics
- Blanchette Rockefeller Neurosciences Institute
- Bluebird Bio
- Blueprint Medicines
- Boehringer Ingelheim
- Bolt Biotherapeutics
- BridgeBio Pharma
- Bristol-Myers Squibb
- Burning Rock
- Cambrooke Therapeutics
- Capitainer
- Capsida Biotherapeutics
- Cardiome Pharma
- Catalent
- CC Pharma
- Celgene
- Cellectricon
- Cellenion
- Cell Guidance Systems
- Centogene
- Century Therapeutics
- Cevec Pharmaceuticals
- Charleston Laboratories
- Chromocell
- Cingulate
- Cipher Pharmaceuticals
- Cisbio Bioassays
- Concordia Pharmaceuticals
- CorTechs Labs
- CRISPR Therapeutics
- CrossBay Medical
- CrossLink Bioscience
- Crown Bioscience
- CSL
- CStone Pharmaceuticals
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- Cumberland Pharmaceuticals
- CureVac
- Curio Genomics
- Cypher Genomics
- Cytokinetics
- CytomX Therapeutics
- Daiichi Sankyo
- DARA BioSciences
- Delic
- Denali Therapeutics
- DePuy
- DexCom
- Dicerna Pharmaceuticals
- Dova Pharmaceuticals
- Dovetail Genomics
- DualityBio
- Dynavax Technologies
- Eagle Genomics
- Eagle Pharmaceuticals
- EA Pharma
- Eckert & Ziegler
- ECMOHO
- eFFECTOR Therapeutics
- Egalet
- Eiger BioPharmaceuticals
- Eisai
- Elanco
- Element Biosciences
- Eli Lilly
- EMD Serono
- Empatica
- Enterome Bioscience
- Epizyme
- Eton Pharmaceuticals
- Eurofins Genomics
- Exact Sciences
- Eyenovia
- Fabric Genomics
- Fate Therapeutics
- Ferring Pharmaceuticals
- Foghorn Therapeutics
- Fortelinea Software Systems
- Fosun Pharmaceutical
- Fusion Pharmaceuticals
- G1 Therapeutics
- Galapagos
- GE Healthcare
- Genentech
- Genmab
- Genome Diagnostics
- Genoox
- Genzyme
- Geron
- Gilead Sciences
- Glenmark Pharmaceuticals
- Goldfinch Bio
- GSK
- GT Research
- H3 Biomedicine
- Halyard Health
- Hanmi Pharmaceutical
- Harbin Pharmaceutical Group
- HarkerBIO
- HD Biosciences
- Heartseed
- Helsinn Healthcare
- Helsinn Therapeutics
- Hepregen
- Heron Therapeutics
- High Beauty
- Hormosan Pharma GmbH
- Human Longevity
- iCAD
- Iconic Therapeutics
- Idorsia
- IGM Biosciences
- Illumina
- Immatics Biotechnologies
- Immunicon
- ImmunityBio
- ImmunoGen
- Immunomedics
- Incyte
- Indegene Lifesystems
- Innara Health
- Innate Pharma
- Innova Biosciences
- Innovent Biologics
- Insitro
- InSphero
- Inspirion Delivery Sciences
- Inspirna
- Integrated DNA Technologies
- Intellia Therapeutics
- Ionis Pharmaceuticals
- Ironwood Pharmaceuticals
- iTeos Therapeutics
- Janssen Biotech
- Janssen Pharmaceuticals
- Jiangsu Alphamab
- Jiangsu Carephar Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Jumpcode Genomics
- Kadmon Pharmaceuticals
- Kailos Genetics
- Kaleo
- Kite Pharma
- Konica Minolta
- Kowa Pharmaceuticals America
- KSQ Therapeutics
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyverna Therapeutics
- Leica Biosystems
- LEO Pharma
- Lexicon Pharmaceuticals
- LG Life Sciences
- Life Genomics AB
- Loxo Oncology
- Lumos Pharma
- Lundbeck
- Luqa Pharmaceuticals
- Luxcel Biosciences
- Lygos
- Macrogenics
- Manchester BIOGEL
- MannKind Biopharmaceuticals
- Medicines360
- MedImmune
- Medovate
- Meiji Seika
- MEI Pharma
- Menarini
- Merck and Co
- Merck KGaA
- Mersana Therapeutics
- Mesoblast
- Metagenomi
- Metavant
- MGC Diagnostics
- Microsoft
- Midatech Pharma
- Miltenyi Biotec
- Mission Pharmacal
- Mitsubishi Chemical
- Mitsubishi Tanabe Pharma
- Mochida Pharmaceutical
- Moderna
- Momenta Pharmaceuticals
- Morphic Therapeutic
- MorphoSys
- MSD
- Multispan
- Myovant Sciences
- Myriad Genetics
- N-of-One
- NantKwest
- NantPharma
- Napo Pharmaceuticals
- Ncardia
- Neotope
- NeraCare
- Nestle Health Science
- Neurexpert
- Neuro3 Therapeutics
- Neurocrine Biosciences
- Neurotrope BioScience
- Nexel
- Next&Bio
- NGM Biopharmaceuticals
- Nkarta Therapeutics
- Norgenix Pharmaceuticals
- NovaBay Pharmaceuticals
- Novartis
- Noven Pharmaceuticals
- Novo Nordisk
- nRichDX
- Numab
- Nurix Therapeutics
- ODI Pharma
- Olympus Medical Systems
- OncoCyte
- OncoSec Medical
- ONK Therapeutics
- Ono Pharmaceutical
- OptiNose
- Orapharma
- OraSure Technologies
- ORFLO Technologies
- Orion
- Otonomy
- Otsuka
- Oxford BioMedica
- Pacific BioScience of California
- Pacific Biosciences
- Pacira Biosciences
- Paragon Bioservices
- Pfizer
- Phil
- Pierian
- Pieris Pharmaceuticals
- Piramal
- Pivot Pharmaceuticals
- Poxel
- Precision BioSciences
- Prelude Therapeutics
- Prevail Therapeutics
- Protagonist Therapeutics
- Protea Biosciences
- Proteos
- Proteovant Therapeutics
- Prothena
- Provention Bio
- PSI (Population Services International)
- Purdue Pharma
- Pure Pharmaceuticals
- QED Therapeutics
- Qiagen
- Quanta
- Radius Health
- Rainbow Scientific
- RainDance Technologies
- Rakuten Medical
- RayBiotech
- Reaction Biology
- Recludix Pharma
- RedHill Biopharma
- RefleXion Medical
- Regeneron Pharmaceuticals
- Regenxbio
- Regulus Therapeutics
- Relay Therapeutics
- Repare Therapeutics
- Resonant Specific Technologies
- Revolution Medicines
- Rigel Pharmaceuticals
- Roche
- Roche Diagnostics
- Roivant Sciences
- Rubicon Genomics
- SAFC
- Sage Therapeutics
- Sajo Consulting
- Salix Pharmaceuticals
- Sangamo Therapeutics
- Sanofi
- Sanofi-Aventis
- Sanofi US Services
- Santen Pharmaceutical
- Sarepta Therapeutics
- Sato Pharmaceutical
- Schrodinger
- Sciex
- Scorpion Therapeutics
- Scribe Therapeutics
- Seagen
- Seattle Genetics
- Seracare Life Sciences
- Seren Pharmaceuticals
- Seres Therapeutics
- Shimadzu
- Shionogi
- Silicon Biosystems
- Simcere Pharmaceuticals
- Sirtex Medical
- Sividon Diagnostics
- SK Biopharmaceuticals
- Solid Biosciences
- Sonoma BioTherapeutics
- Sorrento Therapeutics
- Sosei
- SparingVision
- Spectrum Pharmaceuticals
- SPI Pharma
- Stealth BioTherapeutics
- Stoke Therapeutics
- StrideBio
- STU
- Sumitomo Dainippon Pharma
- Summit Therapeutics
- Suneva Medical
- Sunovion Pharmaceuticals
- Sun Pharmaceutical
- Sutro Biopharma
- Swift Biosciences
- Swixx Biopharma
- Syndax Pharmaceuticals
- Taiho
- Taisho Pharmaceutical
- Takeda Pharmaceutical
- Tango Therapeutics
- Teijin
- Telix Pharmaceuticals
- Terumo Blood and Cell Technologies
- Tetraphase Pharmaceuticals
- Teva Pharmaceutical Industries
- TGR BioSciences
- The Fleury Group
- Theravance
- Thermo Fisher Scientific
- Threshold Pharmaceuticals
- Tilak Healthcare
- Tilray
- Titan Pharmaceuticals
- Tolmar
- TRACON Pharmaceuticals
- Trovita Health Science
- Tyme Technologies
- UCB
- Ultragenyx Pharmaceuticals
- Uni-Bio Science
- Universal Cells
- Urovant Sciences
- US WorldMeds
- Valeant Pharmaceuticals
- Veracyte
- Verity Pharmaceuticals
- Vertex Pharmaceuticals
- Vertice Pharma
- Vifor Pharma
- Vipergen
- ViveBio
- Vivus
- Voyager Therapeutics
- WAVE Life Sciences
- White Labs
- Windsong Radiology
- XCellCure
- Xellia Pharmaceuticals
- Xencor
- ZAI Laboratory
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...